Oxford BioMedica (OTCMKTS:OXBDF) Sees Strong Trading Volume – Still a Buy?

Shares of Oxford BioMedica (OTCMKTS:OXBDF) saw unusually-high trading volume on Monday. 26,442 shares traded hands during trading, an increase of 373% from the average daily volume of 5,590 shares. The stock last traded at $7.27 and had previously closed at $7.25.

Analyst Ratings Changes

Separately, Zacks Research raised Oxford BioMedica to a “hold” rating in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Hold rating. According to data from MarketBeat, the stock presently has an average rating of “Hold”.

Oxford BioMedica Price Performance

The business’s fifty day moving average price is $6.84 and its two-hundred day moving average price is $8.20.

Oxford BioMedica Company Profile

Oxford BioMedica is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company supports biopharmaceutical developers with the design, development, testing and manufacture of viral vectors and other biological materials used in advanced therapies.

Its services include process and analytical development, clinical and commercial-scale manufacturing, quality testing, regulatory support and supply-chain services. Oxford BioMedica has particular expertise in lentiviral vectors, which are used to deliver genetic material into cells, and also provides capabilities involving adeno-associated virus and other vector technologies.

Founded in 1995 and headquartered in Oxford, England, the company serves biotechnology and pharmaceutical customers internationally.